Conference Coverage

Most data reassure regarding TNF inhibitors and cancer


 

EXPERT ANALYSIS FROM PERSPECTIVES IN RHEUMATIC DISEASES 2013

Dr. McInnes disclosed that he has been a speaker, adviser, and/or investigator for Janssen, Roche, Pfizer, BMS, and Novartis. The meeting was held by Global Academy for Medical Education. GAME and this news organization are owned by Frontline Medical Communications.

Pages

Recommended Reading

Biologics May Reduce RA Patients' Risk of Early Death
MDedge Dermatology
Subcutaneous Nodules Linked to Cardiovascular Disease Risk in RA
MDedge Dermatology
Bill seeks to keep biologic copays down
MDedge Dermatology
Anti-TNF drugs don't boost risk of herpes zoster in inflammatory disorders
MDedge Dermatology
All glucocorticoids linked to increased risk of VTE
MDedge Dermatology
Switching anti-TNF drugs of little benefit in psoriatic arthritis
MDedge Dermatology
Preimmunosuppresive hepatitis B screening often goes by the wayside
MDedge Dermatology
Golimumab indication expanded to include ulcerative colitis
MDedge Dermatology
Ustekinumab benefits in PsA sustained through 1 year
MDedge Dermatology
Palmar-plantar psoriasis? Anti-TNF therapy may be culprit
MDedge Dermatology